Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439620 · ClinicalTrials.gov registry record · NA
Optical Frequency Domain Imaging (OFDI) for Biliary Stricture Imaging
A NA study of Biliary Stricture, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT01439620 is a NA study of Biliary Stricture that has completed, run by Massachusetts General Hospital. The registered enrollment target is 7 participants, below the 267-participant average among 3 other Biliary Stricture trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01439620, a NA study of Biliary Stricture, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the potential of comprehensive biliary Optical Frequency Domain Imaging (OFDI) for assessing common bile duct or common hepatic duct strictures, determining cholangiocarcinoma margins, and evaluating primary sclerosing cholangitis (PSC).
Conditions Studied
Interventions
- DEVICE MGH Optical Frequency Domain Imaging (OFDI)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01439620
The ClinicalTrials.gov registry entry for NCT01439620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 3 other Biliary Stricture trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Biliary Stricture appearing as the primary indexed condition, and to 1 intervention - of which MGH Optical Frequency Domain Imaging (OFDI) is the first listed.
NCT01439620 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01439620 about?
NCT01439620 is a clinical study titled "Optical Frequency Domain Imaging (OFDI) for Biliary Stricture Imaging". The goal of this study is to evaluate the potential of comprehensive biliary Optical Frequency Domain Imaging (OFDI) for assessing common bile duct or common hepatic duct strictures, determining cholangiocarcinoma margins, and evaluating primary sclerosing cholangitis (PSC).
What is the current status of trial NCT01439620?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2009-02. Estimated completion is 2010-07-20.
What conditions does trial NCT01439620 study?
This clinical trial studies the following conditions: Biliary Stricture.
What interventions are being tested in trial NCT01439620?
The interventions under investigation include: MGH Optical Frequency Domain Imaging (OFDI) (DEVICE).
Who is sponsoring clinical trial NCT01439620?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01439620 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Stricture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.